Selected article for: "acute trali lung injury and lung injury"
Author: Chun, Sejong; Chung, Chi Ryang; Ha, Young Eun; Han, Tae Hee; Ki, Chang-Seok; Kang, Eun-Suk; Park, Jin Kyeong; Peck, Kyong Ran; Cho, Duck
Title: Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome
  • Document date: 2016_4_25
    • ID: tawmg6g6_1
    Snippet: Dear Editor, Korea suffered from an outbreak of the Middle East Respiratory Syndrome coronavirus (MERS-CoV) in May 2015 [1] . This endemic was the largest to have occurred outside of Saudi Arabia. Currently, a curative treatment for MERS is unavailable. Passive immunotherapy using convalescent plasma from recovering patients is suggested for positive clinical effects [2, 3] . However, the use of human plasma has potential risks including anaphyla.....
    Document: Dear Editor, Korea suffered from an outbreak of the Middle East Respiratory Syndrome coronavirus (MERS-CoV) in May 2015 [1] . This endemic was the largest to have occurred outside of Saudi Arabia. Currently, a curative treatment for MERS is unavailable. Passive immunotherapy using convalescent plasma from recovering patients is suggested for positive clinical effects [2, 3] . However, the use of human plasma has potential risks including anaphylactic shock, transfusion-associated circulatory overload (TACO), and transfusion-related acute lung injury (TRALI) [4] . We describe our experience with administering a convalescent plasma infusion to a MERS patient that resulted in possible TRALI, which might have further accelerated the pulmonary manifestation of MERS in the patient.

    Search related documents:
    Co phrase search for related documents
    • acute lung injury and circulatory overload: 1, 2, 3, 4, 5, 6, 7
    • acute lung injury and clinical effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute lung injury and convalescent plasma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute lung injury and convalescent plasma infusion: 1
    • acute lung injury and curative treatment: 1
    • acute lung injury and human plasma: 1, 2, 3
    • acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and Middle East Respiratory Syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute lung injury and passive immunotherapy: 1, 2
    • acute lung injury and potential risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute lung injury and pulmonary manifestation: 1, 2
    • anaphylactic shock and clinical effect: 1
    • anaphylactic shock and convalescent plasma: 1, 2
    • anaphylactic shock and convalescent plasma infusion: 1
    • anaphylactic shock and lung injury: 1
    • anaphylactic shock and Middle East Respiratory Syndrome coronavirus: 1
    • circulatory overload and convalescent plasma: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • circulatory overload and convalescent plasma infusion: 1
    • circulatory overload and human plasma: 1, 2